Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Double-masked, Randomized, Vehicle-controlled Study of VVN461 Ophthalmic Solution in Treating Post -Operative Ocular Inflammation in Subjects Undergoing Routine Unilateral Cataract Surgery

NCT06164743 is registered in ClinicalTrials.gov with VivaVision Biotech, Inc as lead sponsor.

NCT NCT06164743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06164743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Double-masked, Randomized, Vehicle-controlled Study of VVN461 Ophthalmic Solution in Treating Post -Operative Ocular Inflammation in Subjects Undergoing Routine Unilateral Cataract Surgery
Lead sponsor
VivaVision Biotech, Inc
Phase
Phase 2
Overall status
Completed
Start date
January 11, 2024
Completion date
May 15, 2024
Enrollment
91 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

inflammation